Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, semaglutide and levothyroxine can generally be taken together, but the combination does require some attention. Because semaglutide slows gastric emptying, it can affect how quickly your gut absorbs levothyroxine — a medicine where even small absorption changes can shift your thyroid hormone levels meaningfully. Your prescriber should be aware of both medicines before treatment begins. Semaglutide (sold in the UK as Wegovy) is a prescription-only medicine requiring clinical assessment; a prescriber decides whether it is suitable for you individually, taking your full medication list into account.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works partly by slowing the rate at which your stomach empties into the small intestine. That is useful for appetite control, but it also means that oral medicines taken around the same time may sit in the stomach longer before being absorbed. Levothyroxine is particularly sensitive to this. It is absorbed almost entirely in the upper small intestine, and its absorption is already vulnerable to food, coffee, calcium and iron supplements. A further delay caused by slowed gastric motility can reduce the amount that actually reaches your bloodstream.
Levothyroxine has what pharmacologists call a narrow therapeutic index: the gap between the dose that keeps your thyroid levels stable and the dose that pushes them out of range is small. For most medicines, a modest dip in absorption is a minor inconvenience. For levothyroxine, it can translate into symptoms (fatigue, weight gain, difficulty concentrating, or palpitations) before a blood test confirms anything has shifted. That is why this combination warrants a proper conversation rather than a casual check online. The NHS patient information for semaglutide advises telling your prescriber about all the medicines you take before starting treatment.
None of this means the two medicines cannot be used together. It means managing them thoughtfully, which starts at the consultation stage.
Levothyroxine is already taken on a strict schedule for a good reason. Standard guidance is to swallow it first thing in the morning on an empty stomach, then wait at least 30 minutes before eating, drinking anything other than plain water, or taking other medicines. If you keep that habit (tablet out of the bedside drawer before the kettle goes on, everything else after) that window provides a useful buffer.
Semaglutide is a once-weekly subcutaneous injection, so it is not competing with levothyroxine for a daily time slot in the same way that a twice-daily oral medicine would. The two medicines are not taken at the same moment. What matters is that the background slowing of gastric emptying caused by semaglutide is continuous during the week. The existing 30-minute levothyroxine morning window helps, but it does not fully cancel out the effect of persistently slowed gastric motility. Some people on both medicines find their thyroid function needs re-checking after a few weeks, and occasionally a small dose adjustment to their levothyroxine follows. That is a normal part of managing two medicines that interact at the level of absorption rather than pharmacology.
If you are unsure whether your current levothyroxine timing routine is optimal, your GP is the right person to advise, and starting semaglutide is a reasonable prompt to have that review. Who semaglutide is suitable for covers the broader eligibility picture if you want to read that alongside.
Before any weight-loss treatment begins, declare levothyroxine clearly during your consultation. At nume, every consultation is read by a GPhC-registered Independent Prescriber (a real clinician reviews your full medication list, not a screening algorithm) so this is the moment to flag it. The prescriber can then decide whether any additional monitoring is warranted before approving treatment.
Once on semaglutide, watch for symptoms that can signal thyroid levels drifting. Unusual fatigue coming back after a period of stability, unexpected weight changes beyond what the medicine is producing, or changes in mood or heart rate are all worth reporting to your GP rather than waiting for a scheduled blood test. Your GP may bring forward a thyroid function test six to eight weeks after starting semaglutide or after a dose change, which is sensible practice when absorption-affecting medicines are involved.
On the question of eligibility more broadly, the BMI requirements for Wegovy are a useful starting point if you are still weighing up whether semaglutide is the right option. Thyroid conditions, including hypothyroidism managed with levothyroxine, are not an automatic bar to treatment, but the full clinical picture matters, and that is exactly what the consultation is for. The cost of Wegovy treatment through a private pharmacy is a practical question many people have at this stage too.
It is also worth noting that the MHRA requires patients and prescribers to report suspected side effects or interactions via the Yellow Card scheme, which exists precisely so that real-world signals from combinations like this one can be monitored over time.
Levothyroxine is not the only oral medicine that warrants timing care on semaglutide. Other medicines with narrow therapeutic windows or complex absorption profiles may need similar thought. If you take anything beyond levothyroxine (including supplements, anticoagulants or medicines for blood pressure) listing them all at consultation gives the prescriber the full picture. Pages covering related interactions, such as semaglutide and naproxen or semaglutide and paracetamol, go into more depth on specific medicines if those are relevant to you. For questions about supplements, berberine and semaglutide is covered separately.
If you are ready to go through your medication list with a prescriber, start your free consultation with nume, same-day clinical review, no waiting list.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.